Tarka

Tarka is a brand name of trandolapril/verapamil, approved by the FDA in the following formulation(s):

TARKA (trandolapril; verapamil hydrochloride - tablet, extended release; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: October 22, 1996
  
  Strength(s): 1MG;240MG ^[AB], 2MG;180MG ^[AB], 2MG;240MG ^[AB], 4MG;240MG ^[RLD][AB]

Has a generic version of Tarka been approved?

A generic version of Tarka has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Tarka and have been approved by the FDA:

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (trandolapril; verapamil hydrochloride tablet, extended release; oral)

• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: May 5, 2010
  
  Strength(s): 4MG;240MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: May 26, 2010
  
  Strength(s): 2MG;180MG ^[AB], 2MG;240MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: August 30, 2010
  
  Strength(s): 1MG;240MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tarka. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
  Patent 5,721,244
  Issued: February 24, 1998
  Inventor(s): Becker; Reinhard & Henning; Rainer & Ruger; Wolfgang & Teetz; Volker & Urbach; Hans Jorg
  Assignee(s): Hoechst Aktiengesellschaft
  The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments.
  
  Patent expiration dates:
  
  
  • February 24, 2015
    
  
  

See also...

• Tarka Consumer Information (Wolters Kluwer)
• Tarka Consumer Information (Cerner Multum)
• Tarka Advanced Consumer Information (Micromedex)
• Trandolapril/Verapamil Consumer Information (Wolters Kluwer)
• Trandolapril and verapamil Consumer Information (Cerner Multum)
• Trandolapril and verapamil Advanced Consumer Information (Micromedex)